Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Therapie|January 12, 2020
Use of triptans during pregnancy? With caution!Isabelle Lacroix, Caroline Hurault-Delarue, Delphine Viard, et al.
BMC Infectious Diseases|July 12, 2019
Are current guidelines adapted for patient eligibility to PrEP? A case reportElise K Van Obberghen, Delphine Viard, Alain Lafeuillade, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 23, 2024
Lipschütz ulcer following first dose of COVID-19 tozinameran vaccine: Report of a case and review of a World Health Organization pharmacovigilance databaseElliot Ewig, Nouha Ben Othman, Delphine Viard, et al.
Therapie|November 13, 2023
Drug-induced cardiac toxicity and adverse drug reactions, a narrative reviewAlexandre Destere, Diane Merino, Thibaud Lavrut, et al.
Fundamental & Clinical Pharmacology|December 22, 2018
Spontaneous adverse event notifications by patients subsequent to the marketing of a new formulation of Levothyrox® amidst a drug media crisis: atypical profile as compared with other drugsDelphine Viard, Nadège Parassol-Girard, Serena Romani, et al.
Clinical and Translational Science|September 23, 2020
Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 EpidemicSerena Romani, Alexandre Gérard, Audrey Fresse, et al.
International Journal of Cardiology|October 19, 2020
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problemAudrey Fresse, Delphine Viard, Serena Romani, et al.
Emerging Infectious Diseases|March 21, 2026
Occupational Transmission of Extensively Drug-Resistant Tuberculosis, FranceCorentin Poignon, Frédéric Vandenbos, Karine Risso, et al.
Therapie|May 19, 2020
"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance CentersAlexandre Gérard, Serena Romani, Audrey Fresse, et al.
BMC Pharmacology & Toxicology|August 12, 2025
Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance databaseAlexandre O Gérard, Diane Merino, Nouha Ben Othman, et al.
Pageof 2